Nima Farzan

President & Chief Executive Officer at PaxVax, Inc.

Nima Farzan

Nima Farzan

President & Chief Executive Officer at PaxVax, Inc.

Overview
Career Highlights

PaxVax, Inc.

RelSci Relationships

1447

Number of Boards

1

Contact Data
Trying to get in touch with Nima Farzan? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Nima Farzan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Partner at Ignition Capital Partners

Relationship likelihood: Strong

Co-Head of Global Private Equity & Senior Managing Director at Cerberus Capital Management LP

Relationship likelihood: Strong

Managing Director of Cerberus Capital Management at Cerberus Capital Management LP

Relationship likelihood: Strong

Executive Vice President & Chief Legal Officer at PaxVax, Inc.

Relationship likelihood: Strong

Senior Advisor at Cerberus Operations & Advisory Co. LLC

Relationship likelihood: Strong

Vice Chairman at National Pharmaceutical Council

Relationship likelihood: Strong

President at DTS Aviation Services LLC (Texas)

Relationship likelihood: Strong

Director at Tivorsan Pharmaceuticals, Inc.

Relationship likelihood: Strong

Fellow at Harvard University Advanced Leadership Initiative

Relationship likelihood: Strong

Founding Partner at Ignition Capital Partners

Relationship likelihood: Strong

Paths to Nima Farzan
Potential Connections via
Relationship Science
You
Nima Farzan
President & Chief Executive Officer at PaxVax, Inc.
Education
Unknown

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
President & Chief Executive Officer
2011 - ?

PaxVax, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.

Team Member
Tenure Unconfirmed

doubleTwist Corp. provides software solutions that connect consumers with various types of media. It offers AirSync, which enables its users to sync iTunes playlists, photos, and videos to their Android phones using home Wi-Fi network. The company was founded by Monique Farantzos and Jon Lech Johansen in March 2007 and is headquartered in Austin, TX.

Vice President of Marketing
Prior

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees
Member, Board of Directors
2015 - Current

PaxVax, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nima Farzan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nima Farzan's profile does not indicate a business or promotional relationship of any kind between RelSci and Nima Farzan.